These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8087354)

  • 41. Lung bioavailability of generic and innovator salbutamol metered dose inhalers.
    Clark DJ; Gordon-Smith J; McPhate G; Clark G; Lipworth BJ
    Thorax; 1996 Mar; 51(3):325-6. PubMed ID: 8779143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device.
    Clark DJ; Lipworth BJ
    Thorax; 1996 Oct; 51(10):981-4. PubMed ID: 8977596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction.
    Melchor R; Biddiscombe MF; Mak VH; Short MD; Spiro SG
    Thorax; 1993 May; 48(5):506-11. PubMed ID: 8322237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dry powder inhalers are bioequivalent to metered-dose inhalers. A study using a new urinary albuterol (salbutamol) assay technique.
    Hindle M; Newton DA; Chrystyn H
    Chest; 1995 Mar; 107(3):629-33. PubMed ID: 7874928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.
    Hindle M; Newton DA; Chrystyn H
    Thorax; 1993 Jun; 48(6):607-10. PubMed ID: 8346489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Small bore nozzle extensions to improve the delivery efficiency of drugs from metered dose inhalers: laboratory evaluation.
    Niven RW; Kacmarek RM; Brain JD; Peterfreund RA
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1590-4. PubMed ID: 8503573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Airway mucosal thickening and bronchial hyperresponsiveness induced by inhaled beta 2-agonist in mice.
    Tamaoki J; Tagaya E; Kawatani K; Nakata J; Endo Y; Nagai A
    Chest; 2004 Jul; 126(1):205-12. PubMed ID: 15249464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of an ethanol-free salbutamol sulfate metered-dose inhaler: Application of molecular dynamic simulation-based prediction of intermolecular interaction.
    Aldabet A; Miller JF; Soltani S; Golgoun S; Haroun M; Alkhayer M; Abdelwahed W
    Eur J Pharm Biopharm; 2022 Oct; 179():118-125. PubMed ID: 36058446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Syringe-actuated metered dose inhalers: a quantitative laboratory evaluation of albuterol delivery through nozzle extensions.
    Peterfreund RA; Niven RW; Kacmarek RM
    Anesth Analg; 1994 Mar; 78(3):554-8. PubMed ID: 8109777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of an adrenergic agonist and a cholinergic antagonist on the airway epithelium.
    Konrádová V; Uhlík J; Vajner L; Zocová J
    Vet Med (Praha); 1997 Oct; 42(10):289-93. PubMed ID: 9416009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemoptysis due to MDI therapy in a patient with permanent tracheostomy: treatment with mask AeroChamber.
    Newhouse MT
    Chest; 1999 Jan; 115(1):279-82. PubMed ID: 9925100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new baby-spacer device for aerosolized bronchodilator administration in infants with bronchopulmonary disease.
    Kraemer R; Birrer P; Modelska K; Aebischer CC; Schöni MH
    Eur J Pediatr; 1992 Jan; 151(1):57-60. PubMed ID: 1728549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mucolytic treatment with N-acetylcysteine L-lysinate metered dose inhaler in dogs: airway epithelial function changes.
    Tomkiewicz RP; App EM; Coffiner M; Fossion J; Maes P; King M
    Eur Respir J; 1994 Jan; 7(1):81-7. PubMed ID: 8143836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective observational cohort safety study to monitor the introduction of a non-CFC formulation of salbutamol with HFA134a in England.
    Craig-McFeely PM; Wilton LV; Soriano JB; Maier WC; Shakir SA
    Int J Clin Pharmacol Ther; 2003 Feb; 41(2):67-76. PubMed ID: 12607629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salbutamol disposition and dynamics in conscious rabbits: influence of the route of administration and of the dose.
    Perreault S; Ong H; du Souich P
    J Pharmacokinet Biopharm; 1992 Oct; 20(5):461-76. PubMed ID: 1287197
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of hypoxia and hypercapnia on the kinetics and hypokaliaemic effect of salbutamol in the rabbit.
    Perreault S; Saunier C; Ong H; Du Souich P
    Xenobiotica; 1995 Mar; 25(3):271-81. PubMed ID: 7618353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new method for investigating bioequivalence of inhaled formulations: A pilot study on salbutamol.
    Rezaei H; Khoubnasabjafari M; Jouyban-Gharamaleki V; Hamishehkar H; Afshar Mogaddam MR; Rahimpour E; Mehvar R; Jouyban A
    J Pharm Pharm Sci; 2023; 26():11466. PubMed ID: 37206631
    [No Abstract]   [Full Text] [Related]  

  • 58. Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage.
    Elbeddini A
    J Pharm Policy Pract; 2020; 13():19. PubMed ID: 32454983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two-way coupling and Kolmogorov scales on inhaler spray plume evolutions from Ventolin, ProAir, and Qvar.
    Xi J; Talaat M; Si XA
    Math Biosci Eng; 2022 Aug; 19(11):10915-10940. PubMed ID: 36124575
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of route of administration and dosage form in the pharmacokinetics and bioavailability of salbutamol.
    Hernández RM; Gascón AR; Calvo MB; Caramella C; Conte U; Domínguez-Gil A; Pedraz JL
    Eur J Drug Metab Pharmacokinet; 1997; 22(2):145-50. PubMed ID: 9248783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.